Ketek Tablet Report
Weitz and Luxenberg is no longer accepting Ketek cases.
January 20, 2006, Annals of Internal Medicine published an article reporting three patients who experienced serious liver toxicity following administration of Ketek (telithromycin).
These cases have also been reported to FDA MedWatch. Telithromycin is marketed and used extensively in many other countries, including countries in Europe and Japan.While it is difficult to determine the actual frequency of adverse events from voluntary reporting systems such as the MedWatch program, the FDA is continuing to evaluate the issue of liver problems in association with use of telithromycin in order to determine if labeling changes or other actions are warranted.
As a part of this, FDA is continuing to work to understand better the frequency of liver-related adverse events reported for approved antibiotics, including telithromycin.
Act Now! It is essential that you inquire about your Ketek lawsuit as soon as possible. Your individual state's law may limit your time to bring a legal claim to protect your rights. Your legal review is free and there is no commitment. Your case will be evaluated immediately, so get started on your claim today!
see also:
Ketek Recommendations
Ketek - Recommendations To Healthcare ProvidersThe Danger behind Ketek - A new FDA warning
Did We Know About Liver Problems
Did We Know About Liver Problems Related to Ketek Before Release?The Danger behind Ketek - A new FDA warning
News & Warnings
Breaking Ketek (Telithromycin) News from Dangerous Drug AttorneysBreaking Ketek News & FREE Lawsuit Evaluation from Ketek Attorneys
